MedTrace Logo

The Benefits of a High-intensity Interval Training Intervention Delivered in a School Setting Among Adolescents

NCT06374732 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 369

Last updated 2025-04-24

No results posted yet for this study

Summary

A 12-week school-based high-intensity interval training intervention, with 8 classes of year 7 students randomly allocated to either intervention or control group. The interval training sessions will last for 6 to 10 minutes and will be delivered 5 times per week. Outcome variables will be physical activity, body composition, cardiorespiratory fitness, muscular strength, bone health, executive function, mental wellbeing, and academic performance, which will be measured pre- and post-intervention and two months after the intervention has been completed.

Conditions

  • Healthy

Interventions

BEHAVIORAL

High-intensity interval training

The experimental group will perform 6-to-10-minute of high-intensity interval training at the beginning of their physical education lessons or physical activity lessons.

BEHAVIORAL

Control group

The control group will maintain their normal behaviour, including regular physical education lessons and physical activity lessons.

Sponsors & Collaborators

  • China Scholarship Council

    collaborator UNKNOWN

  • Ningbo University

    collaborator OTHER

  • University of Exeter

    lead OTHER

Principal Investigators

  • Craig Williams, PhD · University of Exeter

  • Yaodong Gu, PhD · Ningbo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
11 Years
Max Age
13 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-26
Primary Completion
2024-10-01
Completion
2024-10-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06374732 on ClinicalTrials.gov